홈 › 난소암 › 텍사스

텍사스의 난소암 임상 시험

난소암 관련 연구 128개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

NEXT Houston, Galveston
NEXT Oncology - PARENT, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07360314

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Parkland Memorial Hospital, Dallas
UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
외 2개

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07001748

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

M D Anderson Cancer Center, Houston

피험자 모집 중

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT05649072

A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT07664735

A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.

NEXT Houston, Houston
NEXT Dallas, Irving

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07778498

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT05739981

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NEXT Austin, Austin
START Center for Clinical Research, Fort Worth
University of Texas MD Anderson Cancer Center, Houston
외 2개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06270706

Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy

MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT06083844

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Hendrick Medical Center, Abilene
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Lyndon Baines Johnson General Hospital, Houston
외 2개

피험자 모집 중2상

전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05564377

A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)

JPS Oncology and Infusion Center ( Site 0019), Fort Worth

피험자 모집 중3상

18세 이상 · 여성 · 2026. 11. 10. 업데이트됨 · NCT07743164

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Texas Oncology - Central/South Texas ( Site 8009), Austin
Texas Oncology - DFW ( Site 8001), Fort Worth
University Of Texas Health Science Center -San Antonio ( Site 0095), San Antonio
외 2개

피험자 모집 중3상

18세 이상 · 여성 · 2026. 11. 10. 업데이트됨 · NCT06824467

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

JPS Health Network ( Site 0084), Fort Worth

피험자 모집 중3상

18세 이상 · 여성 · 2026. 11. 10. 업데이트됨 · NCT07318558

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Parkland Memorial Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
외 7개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06580314

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

Site 0117, Fort Worth

피험자 모집 중3상

18세 이상 · 여성 · 2026. 11. 9. 업데이트됨 · NCT07546500

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

Site 0103, Houston

피험자 모집 중1상

18세 이상 · 여성 · 2026. 11. 9. 업데이트됨 · NCT04516447

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

UT Southwestern Medical Center, Dallas

피험자 모집 중2상

18세 이상 · 여성 · 2026. 11. 6. 업데이트됨 · NCT06787612

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Ben Taub General Hospital, Houston
Memorial Hermann Texas Medical Center, Houston
외 1개

피험자 모집 중

35세 ~ 50세 · 여성 · 2026. 11. 6. 업데이트됨 · NCT04251052

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NEXT Oncology, Austin
UT Southwestern, Dallas

피험자 모집 중1상

19세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06586957

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Total Women's Care of the Heights, Houston
Medical Colleagues of Texas, LLP, Katy

피험자 모집 중관찰 연구

18세 이상 · 여성 · 2026. 11. 5. 업데이트됨 · NCT05051722

A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)

Texas Oncology - West Texas ( Site 8009), Amarillo
Texas Oncology - Central/South Texas ( Site 8002), Austin
Texas Oncology - DFW ( Site 8005), Fort Worth
외 1개

피험자 모집 중3상

18세 이상 · 여성 · 2026. 11. 5. 업데이트됨 · NCT07776691

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06465069

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

USO-Texas Oncology-Central/South Texas, Austin
UT Southwestern Medical Center, Dallas
US Oncology, The Woodlands
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213804

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Texas Oncology, Abilene
Texas Oncology - Central / South Texas, Austin
Mary Crowley Cancer Research, Dallas
외 3개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

The University of Texas - MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06400472

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Texas Oncology - DFW (Sammons CC), Dallas
Baylor College of Medicine, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213791

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06760819

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Texas Oncology - DFW, Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06695845

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

START Dallas Fort Worth, Fort Worth
NEXT Oncology Dallas, Irving

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06303505

CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Clinical Study Site, Austin
Clinical Study Site, Dallas

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07909031

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
NEXT Houston, Houston
NEXT San Antonio, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07524322

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Site 0103 - University of Texas MD Anderson Cancer Center, Houston
Site 0203 - Texas Oncology, Tyler

피험자 모집 중2상

18세 이상 · 여성 · 2026. 10. 30. 업데이트됨 · NCT05128825

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

USA13-0, Anderson
USA12-0, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06953089

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

MD Anderson, Houston
UT Health San Antonio - MD Anderson Cancer Center, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06774963

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

MD Anderson Cancer Center, Houston
START Center for Cancer Research, San Antonio

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07109726

Lead-212 PSV359 Therapy for Patients With Solid Tumors

UT Southwestern University Hospital Radiology Clinic, Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 ~ 90세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06710756

A Study of MGC026 in Participants With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
University of Texas Health Science Center at Houston, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Texas Oncology - West Texas, Amarillo
Texas Oncology, P.A., Dallas
Texas Oncology Gulf Coast, Pearland

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06330064

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Texas Oncology Paris, Fort Worth
Houston Methodist Hospital, Houston
University of Texas - MD Anderson, Houston

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06161025

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06172478

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Mary Crowley Cancer Research, Dallas
University of Texas Southwestern, Dallas

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT04657068

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.